The Company has its main research base and headquarters in Cambridge, UK with a second research base in Monash near Melbourne, Australia and a business development office in San Francisco, USA.
For further information on the company please visit: http://www.stemcellsciences.com.
About Huntington's Disease
Huntington's disease is a familial disease caused by a mutation in the huntingtin gene. Each child of a parent with a mutation in the huntingtin gene has a 50-50 chance of inheriting the mutation. As a result of carrying the mutation, an individual's brain cells fail and die leading to cognitive and physical impairments that, over the course of the disease, significantly impair the individual's quality of life and ultimately causes death. Symptoms of Huntington's disease, which generally develop in midlife and become progressively more debilitating as time passes, can also develop in infancy or old age. Once overt symptoms start, patients live for about 15 to 20 years. One person in 10,000 is believed to carry a mutation in the huntingtin gene. There is currently no way to delay the onset of symptoms or slow the progression of Huntington's disease.
About CHDI Foundation, Inc.
CHDI is a non-profit organization with a mission to rapidly discover
and develop drugs that delay or slow Huntington's disease. CHDI supports an
international network of research laboratories from academia and industry
pursuing novel therapies for the treatment of Huntington's disease. As a
collaborative enabler, CHDI seeks to bring the right partners together to
identify and address critical scientific issues and move drug candidates to
clinical evaluation as quickly as possible. More information about CHDI can
be found at http://www.chdifoundation.org
|SOURCE Stem Cell Sciences plc|
Copyright©2008 PR Newswire.
All rights reserved